Product Safety Recalls

Product Recall Tracker

METHYLPHENIDATE Recall D-0071-2023

Description: Daytrana (methylphenidate transdermal system), Delivers 15 mg over 9 hours, (1.6 mg/hr), 30 patches per box, Rx only, Manufactured for Noven Therapeutics, LLC, Miami, FL 33186; By Noven Pharmaceuticals, Inc., Miami, FL 33186, NDC 68968-5553-3.

METHYLPHENIDATE Recall D-0071-2023 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-0071-2023
Event ID91161
BrandDAYTRANA
Generic NameMETHYLPHENIDATE
ManufacturerMETHYLPHENIDATE
Original Package?1
Active SubstanceMETHYLPHENIDATE
Drug RouteTRANSDERMAL
DistributionNationwide in the USA
Quantity3977 boxes
Recall ReasonDefective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches.
Drug ClassificationClass II
Drug Code Info20221207
Product NDC68968-5552 68968-5553 68968-5554
Product NUIN0000175739 N0000175729
Pharma Class (PE)Central Nervous System Stimulation [PE]
Pharma Class (EPC)Central Nervous System Stimulant [EPC]
Recall Initiation Date20221116
Report Date20221207
Classification Date20221128
Address11960 Sw 144th St
Miami, FL 33186-6109
United States
Recalling FirmNoven Pharmaceuticals Inc
Initial Notification Letter
Unique Ingredient Identifier207ZZ9QZ49
Drug Application NumberNDA021514
Structured Product Labeling (SPL ID)50fce36a-7e6e-4c46-bce9-419884b5162a
Structured Product Labeling (SPL Set ID)2c312c31-3198-4775-91ab-294e0b4b9e7f
Similar To

© 2022 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.